Brief: Pieris Pharmaceuticals Announces 1-For-80 Reverse Stock Split
April 18 (Reuters) - Pieris Pharmaceuticals Inc
PIRS.O :
* PIERIS PHARMACEUTICALS- ANNOUNCES 1-FOR-80 REVERSE STOCK
SPLIT
* PIERIS PHARMACEUTICALS INC: COMMON STOCK TRADING ON A
REVERSE
SPLIT-ADJUSTED BASIS WILL BEGIN AT MARKET OPEN ON TUESDAY, APRIL
23, 2024.
Source text for Eikon: ID:n0001437749-24-012442
Further company coverage: PIRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs